Romlusevimab Antibody
Romlusevimab (BRII-198) is a recombinant human monoclonal antibody designed for research on SARS-CoV-2. It binds to the viral spike protein, exhibiting neutralizing activity in vitro. This makes it a tool for investigating COVID-19 mechanisms and potential therapeutic applications in preclinical studies.
Product Specifications
Product Name Alternative
BRII198, BRII-198
Target
SARS-CoV
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Concentration
14.09 mg/mL
Purity
100.00% (May vary between batches)
Molecular Weight
143.4 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6414734-01 0.1 mL
DUSP4 (Dual Specificity Phosphatase 4, TYP, HVH2, MKP2, MKP-2) (MaxLight 650)
Sign In for Pricing
View Details MBS6414734-02 5x 0.1 mL
DUSP4 (Dual Specificity Phosphatase 4, TYP, HVH2, MKP2, MKP-2) (MaxLight 650)
Sign In for Pricing
View Details 
MBS1166124-01 0.02 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Coenzyme PQQ synthesis protein B (pqqB)
Sign In for Pricing
View Details MBS1166124-02 0.02 mg (Yeast)
Recombinant Xanthomonas campestris pv. campestris Coenzyme PQQ synthesis protein B (pqqB)
Sign In for Pricing
View Details MBS1166124-03 0.1 mg (E-Coli)
Recombinant Xanthomonas campestris pv. campestris Coenzyme PQQ synthesis protein B (pqqB)
Sign In for Pricing
View Details